JDOC.US JPMorgan Healthcare Leaders ETF
- Total assets
- 10.1M
- Expense ratio
- 0.68%
- Dividend yield
- 0.76%
- 1-year return
- +24.00%
- Holdings
- 52
- Since
- 2023
Fund data as reported by the issuer, updated Nov 15, 2026. Total assets are in the fund's base currency.
What does JDOC.US invest in?
- Mostly US stocks (79.4%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (75.3%)
- Top 3 holdings: 22.5% of the fund
Asset allocation
- US stocks 79.4%
- Non-US stocks 22.0%
- Cash 0.8%
Top holdings
- Eli Lilly and Company 8.79%
- AbbVie Inc 8.24%
- UnitedHealth Group Incorporated 5.43%
- Johnson & Johnson 4.71%
- Novartis AG 4.47%
JPMorgan Healthcare Leaders ETF performance
Sharpe ratio 0.00- This year
- +16.22%
- 1 year
- +24.00%
- 3 years
- +13.79%
- 5 years
- -
Volatility 15.9% over 1 year. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
JDOC.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About JPMorgan Healthcare Leaders ETF
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Full fund profileJPMorgan Healthcare Leaders ETF top holdings
48.9% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Eli Lilly and Company LLY.US | Healthcare | United States | 8.79% |
| AbbVie Inc ABBV.US | Healthcare | United States | 8.24% |
| UnitedHealth Group Incorporated UNH.US | Healthcare | United States | 5.43% |
| Johnson & Johnson JNJ.US | Healthcare | United States | 4.71% |
| Novartis AG NOVN.SW | Healthcare | Switzerland | 4.47% |
| Thermo Fisher Scientific Inc TMO.US | Healthcare | United States | 4.24% |
| AstraZeneca PLC AZN.LSE | Healthcare | United Kingdom | 3.93% |
| Merck & Company Inc MRK.US | Healthcare | United States | 3.56% |
| Danaher Corporation DHR.US | Healthcare | United States | 2.84% |
| Intuitive Surgical Inc ISRG.US | Healthcare | United States | 2.69% |
The 10 largest of 52 holdings.
JDOC.US sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
JDOC.US regional exposure
- North America75.3%
- Europe Developed14.8%
- United Kingdom4.9%
- Japan2.0%
- Africa/Middle East1.4%
Share of the stocks in the fund.
Company size
Average market cap 155B- Mega cap23.1%
- Big cap49.8%
- Medium cap20.3%
- Small cap3.1%
- Micro cap1.3%
JPMorgan Healthcare Leaders ETF fund profile
- Fund name
- JPMorgan Healthcare Leaders ETF
- Ticker
- JDOC.US
- Exchange
- USA Stocks
- Issuer
- JPMorgan
- Index tracked
- -
- Category
- Healthcare Equity
- Inception date
- Nov 1, 2023
- Trading currency
- USD
- Expense ratio
- 0.68%
About JPMorgan Healthcare Leaders ETF
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.